Skip to main content
. 2014 Oct 31;10(10):2853–2863. doi: 10.4161/21645515.2014.972131

Figure 3.

Figure 3.

Serotype-specific seropositivity rate (percentage of subjects with PRNT50 titres ≥10 ) 28 d after the first (top) and second (middle) injections, and 1 y (bottom) after the first injection, assessed with PRNT assay using the dengue vaccine candidates’ parental wild-type strains as the challenge virus.